BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 70 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,330,218 | +214.9% | 315,093 | +300.1% | 0.00% | +200.0% |
| Q2 2023 | $2,009,930 | +561333.0% | 78,759 | +367.8% | 0.00% | – |
| Q1 2023 | $358 | -92.8% | 16,836 | -90.0% | 0.00% | -100.0% |
| Q4 2022 | $4,994 | -99.8% | 168,723 | +18.0% | 0.00% | +50.0% |
| Q3 2022 | $3,327,000 | -40.6% | 143,046 | -57.1% | 0.00% | -33.3% |
| Q2 2022 | $5,600,000 | -21.9% | 333,701 | +104.3% | 0.00% | -25.0% |
| Q1 2022 | $7,169,000 | -22.9% | 163,367 | +7.0% | 0.00% | -20.0% |
| Q4 2021 | $9,297,000 | +1404.4% | 152,732 | +650.0% | 0.01% | – |
| Q2 2021 | $618,000 | +138.6% | 20,363 | +41.0% | 0.00% | – |
| Q4 2020 | $259,000 | +0.8% | 14,442 | +7.1% | 0.00% | – |
| Q3 2020 | $257,000 | -9.5% | 13,481 | -26.4% | 0.00% | – |
| Q2 2020 | $284,000 | +24.6% | 18,314 | +20.2% | 0.00% | -100.0% |
| Q1 2020 | $228,000 | +14.0% | 15,241 | -28.1% | 0.00% | – |
| Q4 2019 | $200,000 | -49.5% | 21,190 | -39.1% | 0.00% | -100.0% |
| Q3 2019 | $396,000 | -26.3% | 34,769 | -34.8% | 0.00% | 0.0% |
| Q2 2019 | $537,000 | – | 53,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,915,274 | $57,209,000 | 21.43% |
| Atlas Venture Advisors, Inc. | 612,696 | $18,301,000 | 3.38% |
| Logos Global Management LP | 800,000 | $23,896,000 | 2.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 | $58,484,000 | 1.28% |
| Ghost Tree Capital, LLC | 150,000 | $4,481,000 | 1.05% |
| Parkman Healthcare Partners LLC | 75,454 | $2,254,000 | 0.52% |
| MOODY ALDRICH PARTNERS LLC | 74,060 | $2,212,000 | 0.32% |
| Point72 Asset Management, L.P. | 1,577,493 | $47,120,000 | 0.22% |
| Eventide Asset Management | 411,838 | $12,302,000 | 0.18% |
| SAMLYN CAPITAL, LLC | 437,728 | $13,076,000 | 0.18% |